Deep Singh Email

VP & Head R&D, Precision Delivery . Alcyone Therapeutics

Current Roles

Employees:
41
Revenue:
$6.4M
About
Alcyone Therapeutics is a biotechnology company developing precision therapies for neurological disorders with high unmet medical needs. The company integrates innovation in neuroscience, precision dosing platforms and in-house manufacturing capabilities to deliver transformative therapies to patients. Alcyone leverages the synergy between FalconTM, the company’s proprietary intrathecal precising dosing platform that incorporates deep knowledge of CSF fluid dynamics, computational modeling and bioengineering, and multiple novel genetic therapy platforms developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital (AWRI). This comprehensive approach allows for the optimization of central nervous system (CNS) dosing and delivery to better target the pathophysiology and anatomy specific to various neurological disease areas. Alcyone’s lead programs target the treatment of Rett syndrome and IGHMBP2-Related Diseases (IRD).
Alcyone Therapeutics Address
116 John St
Lowell, MA
United States
Alcyone Therapeutics Email

Past Companies

Alcyone Therapeutics Inc.VP & Head of R&D, Precision Delivery
Alcyone TherapeuticsVice President of R&D, Operations, and Clinical Deployment
Alcyone TherapeuticsProgram Manager

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.